Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin–vinorelbine with a cisplatin–vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study

Maurice Pérol, H. Léna, P. A. Thomas et al. · Annals of Oncology · 2002

Cited by 17 works. doi:10.1093/annonc/mdf128

Authors

References